Machine Learning

With a new CEO who has three FDA-approved drugs to his name, Catalio-backed Rhapsogen is poised to redefine autoimmune disease treatment. Here's why.

The world's biggest music and AI giants partner to revolutionize music discovery and creation, promising an artist-centric approach to end generic AI content.

HiddenLayer joins a massive $151B defense contract to secure AI systems, signaling a new era where protecting AI is critical for national missile defense.

A promising antiviral combination for Long COVID gets a major boost, accelerating its path to a pivotal clinical trial led by top researchers.

InfoWorld recognizes Prophecy for its innovative AI agents that empower business analysts and are disrupting the traditional data pipeline market.

A groundbreaking Duke trial combines a novel device to lure cancer cells with targeted immunotherapy, offering real-time tracking and new hope for patients.

Koddi unveils new AI to move marketers beyond dashboards, using conversational queries and automated budget optimization to supercharge campaign performance.

PayPal is leveraging its vast transaction data to challenge ad giants, offering advertisers a direct view of actual purchases, not just clicks.

With AI reshaping cybersecurity, Ping Identity appoints Adnan Chaudhry as CRO to scale its trusted identity solutions for a new digital landscape.

At CES 2026, LIVALL unveils an AI-powered taillight and helmet ecosystem designed to eliminate blind spots and prevent collisions before they happen.

AVAX One launches an institutional-grade dashboard for its AVAX treasury, a move that could redefine transparency for publicly traded crypto companies.

HR tech leader UKG swept recent 'best workplace' awards. We explore how its people-first philosophy is a strategic weapon in the competitive AI race.

With its massive data library and AI platforms, Tempus AI prepares for a pivotal presentation. What will CEO Eric Lefkofsky reveal to investors?

With major clinical trials, including a novel approach for Alzheimer's, and key market access wins, MMI's Symani system is poised to redefine microsurgery.

With enrollment complete for three major trials, MediciNova braces for a transformative year with crucial data expected for its ALS and metabolic disease candidates.

The FinTech firm's multiple 'Best Places to Work' honors highlight a key strategy for winning the fierce competition for top AI and technology talent.

A new AI-powered system unveiled at CES 2026 promises to grow personalized, nutrient-optimized microgreens right on your countertop.

From your living room to your car, Dolby's latest CES announcements reveal a strategy to embed immersive entertainment into every aspect of your life.

The sale of kACE Financial for up to $119 million marks a strategic pivot for BGC and a power play by smartTrade in the competitive FX tech space.

With top pediatrician Dr. Carol Weitzman on board, EyeContactDX aims to bring its AI-powered ASD screening tool to primary care, promising faster, more equitable diagnosis.